Form 4: Ventyx Biosciences CEO Exercises Stock Options and Disposes of Shares
SEC Form 4 Filing
CEO Raju Mohan exercised stock options and disposed of 96,778 common stock shares at $0.2 on June 10, 2024, according to a Form 4 filing.
Summary
- On June 10, 2024, Raju Mohan, CEO and President of Ventyx Biosciences, Inc., executed a transaction involving the company's stock.
- Mohan exercised stock options to acquire 96,778 shares of common stock at a price of $0.2 per share.
- Concurrently, Mohan disposed of 96,778 shares of common stock.
- Following the reported transaction, Mohan beneficially owns 1,675,028 shares of Ventyx Biosciences common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by the CEO. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CEO, trade in their company's stock. These filings provide transparency to investors about the actions of company leadership.
Stakeholder Impact
- Shareholders may be interested in the CEO's stock transactions as an indicator of management's confidence in the company.
- The filing ensures transparency and compliance with SEC regulations.
Key Dates
| Date | Description |
|---|---|
| April 8, 2024 | Date of Power of Attorney execution. |
| May 1, 2020 | Vesting Commencement Date for the stock options. |
| June 10, 2024 | Date of the stock option exercise and share disposal. |
| June 11, 2024 | Date of signature for the Form 4 filing. |
| May 1, 2030 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.